Annals of Surgical Oncology

• 

  Publication Venue For

  • The Landmark Series-Ductal Carcinoma in Situ: The Evolution of Treatment..  30:3206-3214. 2023
  • ASO Visual Abstract: Trends in Receipt of Adjuvant Chemotherapy and Impact on Survival in Resected Biliary Tract Cancers. 2023
  • Patient-Reported Outcomes of Breast Reconstruction: Does the Quality of Decisions Matter?.  30:1891-1900. 2023
  • ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers—Does One Size Fit All? 2023
  • ASO Author Reflections: Spatial Immunophenotyping of Intraductal Papillary Mucinous Neoplasm..  29:7789-7790. 2022
  • Overcoming Treatment Disparities for Early-Stage Hepatocellular Carcinoma in the Veteran Population: Is the MISSION Act the Solution?.  29:7248-7249. 2022
  • ASO Visual Abstract: Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in MSLT-II.  29:5923-5924. 2022
  • ASO Visual Abstract: Recurrence After Resection of Pancreatic Cancer – Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis?.  29:4977-4978. 2022
  • Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis?.  29:4962-4974. 2022
  • ASO Author Reflections: Decision Support Tools Are Needed to Address Dissatisfaction Among Women Seeking Post-Mastectomy Breast Reconstruction..  29:1120-1121. 2022
  • Serum α-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma..  28:7673-7683. 2021
  • The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034)..  28:2573-2578. 2021
  • ASO Visual Abstract: Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?.  28:1981. 2021
  • Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?.  28:1970-1978. 2021
  • Axillary Downstaging in Occult Primary Breast Cancer After Neoadjuvant Chemotherapy.  28:968-974. 2021
  • A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis..  27:5224-5232. 2020
  • ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer.  27:865-866. 2020
  • Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy..  27:5121-5125. 2020
  • Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers..  27:3318-3327. 2020
  • Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria..  27:2321-2331. 2020
  • A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients..  27:1110-1119. 2020
  • Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines..  27:866-874. 2020
  • ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic Cancer..  26:610-611. 2019
  • Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification..  26:3693-3700. 2019
  • Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer..  26:1657-1668. 2019
  • The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer..  24:1935-1942. 2017
  • Impact of Timeliness of Resection and Thyroidectomy Margin Status on Survival for Patients with Anaplastic Thyroid Cancer: An Analysis of 335 Cases..  22:4166-4174. 2015
  • Society of surgical oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages i and II invasive breast cancer.  21:704-716. 2014
  • A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer..  20:3477-3483. 2013
  • The choice for breast cancer surgery: can women accurately predict postoperative quality of life and disease-related stigma?.  18:2477-2482. 2011
  • Reply to "Totally laparoscopic gastrectomy: A reality for USA and Europe?" (ASO-2009-04-0501.R1).  16:2667. 2009
  • Erratum: A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and leukemia group B study 89903 (Annals of Surgical Oncology (2008) 15 (158-164) DOI: 10.1245/S10434-007-9654-7).  16:2381. 2009
  • Novel Mutant Smoothened in Hepatomas Can Activate Hedgehog Signaling.  16:15-15. 2009
  • Analysis of Hepatic Progenitor Populations in Methyl Deficient Liver Injury.  16:33-33. 2009
  • Breast papillomas in the era of percutaneous needle biopsy..  14:2979-2984. 2007
  • Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma..  14:2824-2830. 2007
  • Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma..  14:2861-2866. 2007
  • Atypical ductal hyperplasia: improved accuracy with the 11-gauge vacuum-assisted versus the 14-gauge core biopsy needle..  14:2497-2501. 2007
  • Treatment and outcome of 82 patients with angiosarcoma..  14:1953-1967. 2007
  • Type and duration of exogenous hormone use affects breast cancer histology..  14:695-703. 2007
  • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology..  14:128-133. 2007
  • Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram..  13:1485-1492. 2006
  • ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes..  13:1296-1321. 2006
  • Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy..  13:1035-1046. 2006
  • Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma..  13:728-739. 2006
  • Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival..  13:582-594. 2006
  • Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial..  13:491-500. 2006
  • Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma..  13:340-346. 2006
  • Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy..  13:66-74. 2006
  • The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer..  12:705-711. 2005
  • Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer..  12:214-221. 2005
  • Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome..  11:955-961. 2004
  • Pancreatic duct strictures: identifying risk of malignancy..  11:581-588. 2004
  • Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?.  11:187-191. 2004
  • Applying the neoadjuvant paradigm to ductal carcinoma in situ..  11:28S-36S. 2004
  • Autofluorescence and diffuse reflectance properties of malignant and benign breast tissues..  11:65-70. 2004
  • Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results..  11:37S-43S. 2004
  • Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study..  10:870-875. 2003
  • Adequacy of distal resection margin following preoperative combined modality therapy for rectal cancer..  10:824. 2003
  • Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer..  10:616-621. 2003
  • Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity..  10:381-388. 2003
  • Randomized multicentric study of perioperative chemotherapy with mitoxantrone in early breast cancer..  10:369-375. 2003
  • Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases..  10:136-143. 2003
  • Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy..  10:80-85. 2003
  • The management of variant arterial anatomy during hepatic arterial infusion pump placement..  9:875-880. 2002
  • Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms..  9:799-806. 2002
  • The surgical management of metastatic melanoma..  9:762-770. 2002
  • Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma..  9:462-466. 2002
  • Final results of the Department of Defense multicenter breast lymphatic mapping trial..  9:248-255. 2002
  • Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer..  9:235-242. 2002
  • Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival..  8:801-806. 2001
  • Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas..  8:758-765. 2001
  • Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV)..  8:644-650. 2001
  • MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer..  8:549-559. 2001
  • The role of lymphoscintigraphy in the management of the patient with breast cancer..  8:354-360. 2001
  • Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < or = 1 cm distal margins sufficient?.  8:163-169. 2001
  • Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration..  8:123-132. 2001
  • Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery..  7:325-332. 2000
  • Cutaneous lymphatic drainage in patients with grossly involved nodal basins..  6:345-349. 1999
  • Cellular and biological therapies of gastrointestinal tumors: overview of clinical trials..  6:218-223. 1999
  • Chemoradiation for localized pancreatic cancer: another perspective..  6:4-7. 1999
  • Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas..  6:38-45. 1999
  • Sphincter-sparing treatment for distal rectal adenocarcinoma..  6:433-441. 1999
  • Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]..  5:681-688. 1998
  • Malignant melanoma of the mucous membranes: a review of 119 cases..  5:733-742. 1998
  • Volume of resection in patients treated with breast conservation for ductal carcinoma in situ..  5:757-763. 1998
  • Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer..  5:522-528. 1998
  • Cell cycle regulation of human pancreatic cancer by tamoxifen..  5:342-349. 1998
  • Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma..  5:376-383. 1998
  • Contributions from surgeons to clinical trials and research on the management of soft tissue sarcoma..  5:437-441. 1998
  • Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome..  4:644-649. 1997
  • Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment..  4:198-202. 1997
  • Importance of race on breast cancer survival..  4:80-87. 1997
  • Leiomyosarcoma in childhood and adolescence..  4:223-227. 1997
  • Evaluation of new putative tumor markers for melanoma..  3:558-563. 1996
  • Immunological memory induced by genetically transduced tumor cells..  3:247-254. 1996
  • Age as a prognostic factor in the malignant melanoma population..  1:487-494. 1994
  • T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice..  1:405-410. 1994
  • Malignant melanoma in children..  1:278-282. 1994
  • Lobular carcinoma in situ: observation without surgery as an appropriate therapy..  1:141-146. 1994
  • Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma..  1:111-116. 1994
  • Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?.  14:2437-2439. 2007
  • Local excision of rectal cancer revisited: ACOSOG protocol Z6041..  14:271. 2007
  • The surgeon and adjuvant therapy for stage II colon cancer..  14:272-273. 2007
  • Coin of the realm.  13:901. 2006
  • Erratum: The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer (Annals of Surgical Oncology (September 2005) 12 (9) (705-711) DOI: 10.1245/ASO.2005.08.020).  12:952. 2005
  • A pilot study of preoperative chemoradiation for gastric cancer..  8:482-483. 2001
  • Surrogate markers of effective anti-tumor immunity..  8:190-191. 2001
  • Is intraoperative lymph node mapping and sentinel lymph node biopsy for colorectal carcinoma necessary?.  7:82-84. 2000
  • Preoperative radiotherapy for rectal cancer: benefits and controversies..  3:419-420. 1996
  • Laparoscopic colectomy for cancer: a favorable opinion..  2:3-5. 1995
  • A comparison of risk perceptions in patients with DCIS or atypical breast lesions 2022
  • Association Between Overall Survival and Chemotherapy Receipt According to Age and 21-gene Recurrence Score 2022
  • Cost Communication in Breast Cancer Surgery 2022
  • Disease Progression and Trends in the Management of in Transit Melanoma 2022
  • In-transit Melanoma: A Multi-institutional Analysis of Outcomes 2022
  • Machine learning-based epigenetic classifiers to identify lymph node metastases in breast cancer patients with ER-positive, HER2-negative invasive ductal carcinoma 2022
  • Neoadjuvant Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer: Comparison of Chemotherapy and Endocrine Approaches 2022
  • Pancreatic Ductal Amylase: A Novel Marker and Approach to the Assessment of Postoperative Pancreatic Fistula 2022
  • Perioperative and Oncologic Outcomes of Hepatic Artery Infusion Pump Therapy at an Expanding HAI Program 2022
  • Predicting Disparities in Receipt of Guideline-concordant Care (GCC) for Breast Cancer 2022
  • Spatial Biology Analysis Reveals the Location and Activation of B Cells in Sentinel Lymph Nodes Correlate with Prognosis in Melanoma Patients 2022
  • Spatial Transcriptome Profiling of Intraductal Papillary Mucinous Neoplasms Nominates Novel Cyst Fluid Biomarkers of High-grade Dysplasia 2022
  • The breast life in BRCA: Imaging and biopsy burden for BRCA1/2 patients 2022
  • The rate of incidental breast cancer in women with BRCA1/2 mutations who undergo bilateral risk-reducing mastectomy 2022
  • Survival Outcomes Among Patients with Metastatic Breast Cancer: Review of 47,000 Patients. 2021
  • A Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma 2021
  • Improving the Patient Experience for Women Undergoing Breast Surgery: Yes, There's an App for That, Too! 2021
  • Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma 2021
  • Risk Factors for Gastric Cancers in the US: Variation by Anatomic Site and Race/Ethnicity 2021
  • Serum Pepsinogen as a Biomarker for Gastric Cancer: A Nested Case-Control Study Using the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Data 2021
  • 40-Minutes is Enough: Lymphoscintigraphy with Novel Agent Reduces Time Needed for Mapping 2020
  • Active Surveillance of Melanoma Patients with Sentinel Node Metastasis: An International Multi-Institution Evaluation of Post-MSLT-2 Adoption and Early Outcomes 2020
  • An Immune Tolerant Sentinel Node Microenvironment Predicts Recurrence in Melanoma 2020
  • CD226 Expression is Associated with Increased Survival in Pancreatic Cancer 2020
  • Expression of CD155, PD-1 and PD-L1 in Non-Melanoma Skin Cancer: Implications for Treatment of Advanced Disease 2020
  • Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and Australia 2020
  • Textbook Outcomes Among Patients Undergoing Retroperitoneal Sarcoma Resection. 2020
  • The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed with Intraductal Papilloma without Atypia by Core Needle Biopsy (TBCRC 034) 2020
  • Increased Use of Neoadjuvant Chemotherapy in Women With Early-stage Breast Cancer 2020
  • Surgery for Men with Breast Cancer: Do the Same Data Still Apply? 2020
  • Variable Practice Patterns in a Contemporary Multi-institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrate a Need for More Individualized Margin Guidelines 2020
  • Anxiety scores of women with an increased risk of breast cancer participating in facilitated group visits 2019
  • Evolving role of Oncotype DX (R) following TailoRx 2019
  • A Distinct Genomic Profile is Associated with Conversion to Resection and Survival in Initially Unresectable Colorectal Liver Metastasis 2019
  • Extent of Lymphadenectomy in Patients with Melanoma and Clinical Node Disease 2019
  • Long-Term Follow-up of FOLFIRINOX Induction Therapy for Locally Unresectable Pancreatic Ductal Adenocarcinoma (PDAC) 2019
  • Overall Survival Improved for Contemporary Patients with Melanoma 2019
  • Substage-Specific Survival in Acral Lentiginous Melanoma 2019
  • Targeting DAMPs-Induced Inflammation in Breast Cancer 2019
  • Undertreatment of the Elderly with Rectal Cancer: Outcomes from the National Cancer Data Base 2019
  • Extent of axillary surgery in women with Stage IV breast cancer 2018
  • Patient preferences for DCIS treatment strategies: A discrete-choice experiment 2018
  • A Scoring System to Estimate Perioperative Mortality Following Liver Resection for Hepatocellular Carcinoma 2018
  • Breast Cancer Treatment Costs: Surgical Decisions and Preferences for Transparency 2018
  • Clinical and Pathologic Stage Discordance is Associated with Breast Cancer Prognosis 2018
  • Is the Number of Sentinel Lymph Nodes Important for Head and Neck Melanoma Staging? 2018
  • Measuring the Quality of Gastric Cancer Care in the United 2018
  • Neo-adjuvant Chemotherapy Improves Survival Compared to Neo-adjuvant Radio-Chemotherapy Among Gastric Cardia Cancer Patients 2018
  • Race, Marital Status and Stage are Associated with Patient-Reported Distress After Breast Cancer Diagnosis: A Review of > 5000 Patient Visits 2018
  • Treatment Patterns and Outcomes for Breast Cancer with Isolated Supraclavicular Metastases 2018
  • Multidisciplinary management of the axilla in patients with cT1-2N0 breast cancer undergoing mastectomy: results from a prospective single institution series 2017
  • Patient age and tumor subtype predicts adherence to ACOSOG Z0011 recommendations: Analysis of national practice patterns 2017
  • Surgical resection of the primary tumor in women with stage IV breast cancer: Contemporary practice patterns and survival analysis 2017
  • The Impact of Axillary Surgery on Women with N2-N3 Invasive Breast Cancer 2017
  • Factors Associated with Adjuvant Radiotherapy for Stage III Melanoma: A National Study of 15361 Patients 2017
  • Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous Cell Carcinoma 2017
  • Multicenter Study of the Prognostic Value of Sentinel Lymph Node Biopsy in the Management of Recurrent Melanoma 2017
  • Factors Associated With the Decision to Pursue Elective Surgery Among Women Enrolled in TBCRC013: A Prospective Registry of Surgery in Patients Presenting With Stage IV Breast Cancer 2016
  • Frequent BRAF Mutations in Colonic High-Grade Neuroendocrine Carcinoma 2016
  • Implementation of the Distress Thermometer Among Surgical Breast Cancer Patients at a Comprehensive Breast Center 2016
  • Local Excision has Comparable Survival to Abdominoperineal Resection in Patients with Anal Melanoma: An Analysis of 760 Patients from the National Cancer Data Base 2016
  • Lymph Node Yield Between Open and Laparoscopic Portal Lymphadenectomy 2016
  • National Practice Patterns Among Women with Stage IV Breast Cancer Undergoing Surgery at the Primary Site 2016
  • Radiation Therapy is Associated with Improved Survival for Retroperitoneal Sarcoma: A Contemporary Analysis of 9,068 Patients 2016
  • The Utility of Screening MRI for Women Diagnosed with Atypical Breast Lesions 2016
  • Hospital Selection and Breast Cancer Patients: Who Goes Where 2015
  • A Phase I Clinical Trial of LUM015: A Protease-activated Fluorescent Imaging Agent to Detect Cancer during Surgery 2015
  • Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients with Melanoma (SAFE-MILND) 2015
  • Factors Associated With Surgeons' Decisions to Refer Early-Stage Breast Cancer Patients to an Oncologist for Consideration of Neoadjuvant Therapy 2015
  • Disease Burden Predicts Response to Melphalan-based Isolated Limb Infusion in Melanoma 2014
  • Impact of Pre-treatment Imaging on Survival of Esophagectomy after Induction Therapy for Esophageal Cancer: Who Should be Given the Benefit of Doubt? 2014
  • Incidence Patterns of Breast Cancer among Women 35 and Younger at Diagnosis 2014
  • Neoadjuvant Radiation does not Increase Morbidity following Resection of Retroperitoneal Sarcoma 2014
  • Open versus Minimally Invasive Management of Gastric Gastrointestinal Stromal Tumors: An International Multi-institutional Analysis of Short- and Long-term Outcomes 2014
  • The Cumulative Impact of Breast Irradiation on Chest Wall Angiosarcoma: A 40-year Outcome Study 2014
  • The Impact of Surveillance after Lobectomy for Stage IA Non-small Cell Lung Cancer 2014
  • Use of Neoadjuvant Tyrosine-kinase Inhibitors can Aid in Resection of Gastrointestinal Stromal Tumors 2014
  • Accurately Predicting a Negative Axilla After Positive Sentinel Node Biopsy 2013
  • Impact of Race in Prevalence of BRCA Mutations Among Women With Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort 2013
  • Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer: A Review of the National Comprehensive Cancer Network (NCCN) Database 2013
  • Neoadjuvant Chemoradiation in Patients Undergoing Pancreaticoduodenectomy: Do the Ends Justify the Means? 2013
  • Outcomes after Mastectomy for Node-positive Breast Cancer: Comparison of Women Treated With and Without Completion Axillary Dissection at NCCN Cancer Centers 2013
  • Post-operative Surveillance of Ductal Carcinoma In Situ 2013
  • Sentinel Lymph Node Biopsy to Guide Management in Patients with Locally Recurrent Melanoma 2013
  • Termination of BRAF Targeted Therapy Augments Tumor Growth in the Setting of Vemurafenib Resistance 2013
  • Peritumoral Expression of Adipokines and Fatty Acids in Breast Cancer 2013
  • Atypical Ductal Hyperplasia of the Breast: Does Size of Core Needle Biopsy Matter? 2012
  • Is There a Role for Radiotherapy in the Management of Retroperitoneal Sarcoma: A Single Institutional Experience 2012
  • Laparoscopic vs. Open Resection for Rectal Cancer: A Comparison of Short-term Outcomes 2012
  • Neoadjuvant Aromatase Inhibitor Therapy Permits Breast Conservation in Postmenopausal Women with Large, Estrogen Receptor (ER)-Rich Breast Cancer Facing Mastectomy: Results from The American College of Surgeons Oncology Group (ACOSOG) Z1031 Trial 2012
  • Patterns of Recurrence following Complete Response to Regional Chemotherapy for In-transit Melanoma 2012
  • The Impact of Vascular Reconstruction on Early Postoperative Outcomes after Pancreaticoduodenectomy: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program Database 2012
  • Unique Considerations for Performing Upper Extremity (UE) Isolated Limb Infusions (ILI) 2012
  • Does neoadjuvant therapy improve survival in patients with resectable pancreatic cancer? 2010
  • Final Results of a Prospective Multi-Center Phase II Trial of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients with Advanced Extremity Melanoma 2010
  • Limb Preservation with Isolated Limb Infusion for Unresectable Non-melanoma Cutaneous and Soft Tissue Malignancies 2010
  • Paradoxical Effects of Smo Proto-Oncogene Overexpression in Hepatocytes 2010
  • Patterns of Recurrence in Melanoma and the Impact on Survival 2010
  • Prospective Evaluation of PET/CT as a Surveillance Tool to Define Response to Therapy and Identify New Recurrent Disease in Patients with Locally Advanced Melanoma Undergoing Regional Chemotherapy Treatment with Melphalan 2010
  • Tumor Sampling Variables Affect Reproducibility of Predictive Gene Expression Signatures in Breast Cancer 2010
  • Near-margin adventitial (NMA) vascular dissection is equivalent to en bloc vascular resection in soft tissue sarcomas (STS) 2009
  • Targeting N-cadherin to Enhance Cytotoxicity of Melphalan in Regional Chemotherapy: Final Results of a Phase I Study of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients (pts) with Locally Advanced In-transit Malignant Melanoma 2009
  • Tumor size and lymph node status in breast cancer: can gene expression patterns delineate between clinical phenotypes? 2009
  • Isolated limb infusion for in-transit malignant melanoma of the extremity: A well tolerated but less effective alternative to hyperthermic isolated limb perfusion 2008
  • The pattern of metastasis influences survival after pancreatic resection of renal cell carcinoma metastases 2008
  • A phase II prospective, multi-institutional trial (CALGB 89903) of adjuvant active specific immunotherapy following curative resection of colorectal cancer(CRC) hepatic metastases 2007
  • Do isolated tumor cells in the sentinel node in melanoma affect long-term prognosis? 2007
  • Down-regulation of Sphingosine 1-Phosphate receptor-1 in intestinal tumorigenesis 2007
  • Hepatic imaging characteristics predict overall survival in hepatocellular cancer 2007
  • Simultaneous resections of colorectal cancer and synchronous liver metastases: an anal sis of safety and long-term outcome 2007
  • Targeted therapy for in-transit melanoma: Utility of gene expression signatures to define optimal strategy 2007
  • Role of BAY 43-9006 in combination with temozolomide and melphalan in metastatic melanoma 2006
  • The role of chemoresistance in regional infusion therapy for melanoma 2006
  • Application of clinico-genomic models that predict breast cancer characteristics in a prospective study 2005
  • Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial 2005
  • Three month follow up for ACOSOG Z0020, a prospective randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone versus melphalan plus tumor necrosis factor 2005
  • Effects of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy 2004
  • Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma 2004
  • In vivo expression of an adenoviral vector encoding soluble tie2 inhibits metastatic hepatic tumor growth 2004
  • Prognostic significance of histologic response to preoperative chemoradiation for pancreatic cancer 2004
  • Role of hyperthermia in regional alkylating agent chemotherapy 2004
  • Specific active immunotherapy for primary melanoma: Experience with 5399 Patients 2004
  • The onset of genomic instability in sporadic colorectal polyps 2004
  • Vitamin E acetate decreases tamoxifen efficacy in human breast cancer xenografts 2004
  • Auto fluorescence and diffuse reflectance properties of malignant and benign breast tissues 2003
  • I-131-meta-iodobenzylguanidine treatment for metastatic carcinoid tumors in 98 patients 2003
  • Prognostic significance of histologic response to preoperative chemoradiation for periampullary tumors 2003
  • Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms 2002
  • Incidence of invasive breast cancer following initial diagnosis of nonpalpable ductal carcinoma in-situ by stereotactic core needle biopsy 2002
  • Pancreatic duct strictures without an associated common bile duct stricture: Identifying risk of malignancy 2002
  • Pathologic features affecting detection of metastasis in breast cancer sentinel lymph nodes during intraoperative frozen section analysis 2002
  • Preoperative 5-FU and radiation therapy increases sphincter preservation rates and improves R0 resection rates for rectal cancer 2002
  • Prospective evaluation of the accuracy of lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for locally advanced breast cancer 2002
  • Thoracic paravertebral blockade for breast sentinel lymph node biopsy: Experience in 137 patients 2002